Viewing Study NCT03660657


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-25 @ 4:58 PM
Study NCT ID: NCT03660657
Status: TERMINATED
Last Update Posted: 2022-04-04
First Post: 2018-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ozone Therapy in Refractory Ischemic Heart Disease.
Sponsor: Bernardino Clavo, MD, PhD
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: O3Cardio
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View